NO995245L - Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering - Google Patents

Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering

Info

Publication number
NO995245L
NO995245L NO995245A NO995245A NO995245L NO 995245 L NO995245 L NO 995245L NO 995245 A NO995245 A NO 995245A NO 995245 A NO995245 A NO 995245A NO 995245 L NO995245 L NO 995245L
Authority
NO
Norway
Prior art keywords
medications
manufacture
treat diseases
diseases causing
tetrahydropyridine derivatives
Prior art date
Application number
NO995245A
Other languages
English (en)
Other versions
NO325163B1 (no
NO995245D0 (no
Inventor
Bernard Bourrie
Pierre Casellas
Jean-Pierre Maffrand
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO995245D0 publication Critical patent/NO995245D0/no
Publication of NO995245L publication Critical patent/NO995245L/no
Publication of NO325163B1 publication Critical patent/NO325163B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO19995245A 1997-04-29 1999-10-27 Anvendelse av tetrahydropyridinderivater NO325163B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705275A FR2762514B1 (fr) 1997-04-29 1997-04-29 Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
PCT/FR1998/000774 WO1998048802A1 (fr) 1997-04-29 1998-04-17 Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation

Publications (3)

Publication Number Publication Date
NO995245D0 NO995245D0 (no) 1999-10-27
NO995245L true NO995245L (no) 1999-12-27
NO325163B1 NO325163B1 (no) 2008-02-11

Family

ID=9506415

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995245A NO325163B1 (no) 1997-04-29 1999-10-27 Anvendelse av tetrahydropyridinderivater

Country Status (18)

Country Link
US (1) US6344464B1 (no)
EP (1) EP0979079B1 (no)
JP (1) JP3956059B2 (no)
AR (1) AR012504A1 (no)
AT (1) ATE269077T1 (no)
AU (1) AU7436498A (no)
BR (1) BR9810234A (no)
CA (1) CA2288241C (no)
DE (1) DE69824576T2 (no)
DK (1) DK0979079T3 (no)
ES (1) ES2222593T3 (no)
FR (1) FR2762514B1 (no)
NO (1) NO325163B1 (no)
PT (1) PT979079E (no)
SI (1) SI0979079T1 (no)
UY (1) UY24973A1 (no)
WO (1) WO1998048802A1 (no)
ZA (1) ZA983602B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
FR2823748B1 (fr) * 2001-04-20 2004-02-20 Sanofi Synthelabo Tetrahydropyridyl-alkyl-benzodiazines, procede pour leur preparation et compositions pharmaceutiques les contenant
EP1383762B1 (fr) * 2001-04-20 2007-06-20 Sanofi-Aventis Tetrahydropyridyl-alkyl-heterocycles, procede pour leur preparation et compositions pharmaceutiques les contenants
DK2270052T3 (en) 2001-06-26 2018-07-02 Amgen Inc Antibodies to OPGL
WO2003002187A2 (en) * 2001-06-26 2003-01-09 Photomed Technologies, Inc. Multiple wavelength illuminator
FR2831166B1 (fr) * 2001-10-18 2004-02-27 Sanofi Synthelabo Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant
WO2004022718A2 (en) 2002-09-06 2004-03-18 Amgen, Inc. Therapeutic human anti-il-1r1 monoclonal antibody
CA2511823A1 (en) * 2002-12-30 2004-07-22 Amgen Inc. Combination therapy with co-stimulatory factors
US7838522B2 (en) 2004-11-17 2010-11-23 Ares Trading S.A. Benzothiazole formulations and use thereof
SI1828160T1 (sl) 2004-12-21 2012-01-31 Merck Serono Sa Sulfonil amino cikliäśni derivati in njihova uporaba kot mmp-inhibitorji
PL1844032T3 (pl) 2005-01-31 2011-09-30 Merck Serono Sa Pochodne N-hydroksyamidu i ich zastosowanie
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
WO2007009959A1 (en) * 2005-07-15 2007-01-25 Laboratoires Serono S.A. Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders
KR20080050591A (ko) 2005-09-01 2008-06-09 아레스 트레이딩 에스.에이. 시신경염 치료
CA2722611A1 (en) * 2007-11-21 2009-05-28 Decode Genetics Ehf Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
KR101707597B1 (ko) * 2010-12-07 2017-02-17 한국전자통신연구원 홀 센서리스 ｂｌｄｃ 모터용 전원 공급 모듈
EP3836954A1 (en) 2018-08-13 2021-06-23 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
WO2023118544A1 (en) 2021-12-23 2023-06-29 Cilcare Dev 4-phenyl-tetrahydropyridine derivatives for treating hearing diseases
WO2023222565A1 (en) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531707A1 (fr) 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
FR2662355B1 (fr) 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
FR2740343B1 (fr) 1995-10-26 1999-01-22 Sanofi Sa Utilisation de la 1-(2-napht-2-yl-ethyl)-4- (3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de la sclerose laterale amyotrophique

Also Published As

Publication number Publication date
JP2002501498A (ja) 2002-01-15
ZA983602B (en) 1998-11-02
EP0979079B1 (fr) 2004-06-16
UY24973A1 (es) 1998-07-16
NO325163B1 (no) 2008-02-11
CA2288241A1 (en) 1998-11-05
ES2222593T3 (es) 2005-02-01
JP3956059B2 (ja) 2007-08-08
DE69824576D1 (de) 2004-07-22
FR2762514B1 (fr) 1999-10-22
AR012504A1 (es) 2000-10-18
FR2762514A1 (fr) 1998-10-30
BR9810234A (pt) 2000-09-19
SI0979079T1 (en) 2004-10-31
AU7436498A (en) 1998-11-24
NO995245D0 (no) 1999-10-27
EP0979079A1 (fr) 2000-02-16
US6344464B1 (en) 2002-02-05
WO1998048802A1 (fr) 1998-11-05
ATE269077T1 (de) 2004-07-15
DK0979079T3 (da) 2004-10-25
PT979079E (pt) 2004-10-29
DE69824576T2 (de) 2005-06-30
CA2288241C (en) 2006-10-03

Similar Documents

Publication Publication Date Title
NO995245L (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
NO995221D0 (no) Sulfonamider for behandling av endotelinmedierte sykdommer
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
NO990225D0 (no) Medikamenter for behandling av hyperfosfatemi
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
NO20000062L (no) Prostaglandinderivater fri for bieffekter for behandlingen av glaukom
NO20041007L (no) Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat
NO995723L (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO995722D0 (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20020784L (no) Medikament for behandling av brudd
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
NO20014953L (no) Anvendelse av osanetant for fremstilling av medikamenter anvendt for å behandle sinnsstemningslidelser
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO308583B1 (no) Anvendelse av steroider for fremstilling av et medikament for behandling av forstyrrelser indusert av østrogenmangel, steroidene samt farmasøytisk blanding
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner